Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -37.04% | 143.47% | -38.03% | -23.04% | -21.73% |
| Total Receivables | 22.29% | -86.08% | 337.21% | -49.61% | -85.54% |
| Inventory | -45.81% | -14.35% | -5.31% | -32.03% | 50.98% |
| Prepaid Expenses | 58.30% | -26.20% | 14.61% | -8.22% | 9.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Current Assets | -32.68% | 99.38% | -28.44% | -20.32% | -25.98% |
|
|
|||||
| Total Current Assets | -32.68% | 99.38% | -28.44% | -20.32% | -25.98% |
| Net Property, Plant & Equipment | -9.09% | -3.66% | 42.59% | -2.79% | -6.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -100.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.02% | -16.75% | -17.86% | -39.18% | 2.56% |
| Total Assets | -27.17% | 56.96% | -41.38% | -13.03% | -16.31% |
|
|
|||||
| Total Accounts Payable | 15.85% | -36.52% | 140.91% | -17.31% | -43.97% |
| Total Accrued Expenses | -29.17% | 16.08% | 84.71% | 25.56% | -43.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.95% | -2.49% | 13.08% | 3.77% | 9.69% |
| Total Finance Division Other Current Liabilities | 344.03% | -62.85% | -59.47% | 53.27% | 59.12% |
| Total Other Current Liabilities | 344.03% | -62.85% | -59.47% | 53.27% | 59.12% |
| Total Current Liabilities | -14.32% | -0.58% | 57.64% | 15.15% | -31.30% |
|
|
|||||
| Total Current Liabilities | -14.32% | -0.58% | 57.64% | 15.15% | -31.30% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -29.99% | -22.66% | 10.53% | -16.63% | -11.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.59% | -13.00% | -1.11% | 7.36% | 6.64% |
| Total Liabilities | -0.74% | -10.66% | 7.69% | 7.52% | -1.44% |
|
|
|||||
| Common Stock & APIC | 0.17% | 6.79% | 0.19% | 0.15% | 0.16% |
| Retained Earnings | -2.78% | -1.07% | -6.08% | -2.96% | -2.73% |
| Treasury Stock & Other | -5.63% | -17.44% | 0.00% | 1.18% | 107.32% |
| Total Common Equity | -99.22% | 66.02% | -242.15% | -937.52% | -89.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -99.22% | 66.02% | -242.15% | -937.52% | -89.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -99.22% | 66.02% | -242.15% | -937.52% | -89.25% |
|
|
|||||